Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liquid biopsy and its role in an advanced clinical trial for lung cancer.

Experimental biology and medicine (Maywood, N.J.) - 1 Feb 2018

Johann Donald J, Steliga Mathew, Shin Ik J, Yoon Donghoon, Arnaoutakis Konstantinos, Hutchins Laura, Liu Meeiyueh, Liem Jason, Walker Karl, Pereira Andy, Yang Mary, Jeffus Susanne K, Peterson Erich, Xu Joshua

Abstract excerpt

Liquid biopsy methodologies, for the purpose of plasma genotyping of cell-free DNA (cfDNA) of solid tumors, are a new class of novel molecular assays. Such assays are rapidly entering the clinical sphere of research-based monitoring in translational oncology, especially for thoracic malignancies. Potential applications for these blood-based cfDNA assays include: (i) initial diagnosis, (ii) response to therapy and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell-Free Nucleic Acids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Decision-Making

Share to DNA, Neoplasm

Share to Liquid Biopsy

Share to Lung Neoplasms

Share to Neoplasm, Residual

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 29405770
DOI: 10.1177/1535370217750087
PMCID: PMC5813874

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liquid biopsy and its role in an advanced clinical trial for lung cancer.PMID 29405770Read ↗

Liquid biopsy tracking of lung tumor evolutions over timeSemantic proximity Read ↗

Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative Review.Semantic proximity Read ↗

Clinical Utility of ctDNA Analysis in Lung Cancer—A ReviewSemantic proximity Read ↗

The evolving role of liquid biopsy in lung cancer.Semantic proximity Read ↗

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.Semantic proximity Read ↗

[Applications and limitations of liquid biopsy : Applications and methodological limitations of cell-free DNA analysis in tumor diagnostics].Semantic proximity Read ↗

Liquid biopsy enters the clinic - implementation issues and future challenges.Semantic proximity Read ↗

Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.Semantic proximity Read ↗

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Semantic proximity Read ↗

Liquid biopsy: current technology and clinical applicationsSemantic proximity Read ↗

Liquid Biopsy in the Clinical Management of CancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.